Evidence map›Paper›PMID 18160709›Full record

ArticleMolecular and cellular biology2008

Myocyte enhancer factor 2 and chorion factor 2 collaborate in activation of the myogenic program in Drosophila.

Kathleen K Kelly Tanaka, Anton L Bryantsev, Richard M Cripps

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Analysis of skeletal muscle development in Drosophila.Methods in molecular biology (Clifton, N.J.) · 2012
    Article
  16. Article
  17. Article
  18. Cardiac gene regulatory networks in Drosophila.Biochimica et biophysica acta · 2009
    Review
  19. Cardiac expression of the Drosophila Transglutaminase (CG7356) gene is directly controlled by myocyte enhancer factor-2.Developmental dynamics : an official publication of the American Association of Anatomists · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kathleen K Kelly TanakaDepartment of Biology, University of New Mexico, Albuquerque, NM 87131, USA.
Anton L Bryantsev
Richard M Cripps
University of New Mexico · US

Funding

UNM COBRE: THEORETICAL STUDY OF SPECIFICITY OF RNA SILENCING MECHANISMP20RR018754 · NCRR · UNIVERSITY OF NEW MEXICO · PI LOKER, ERIC SAMUEL · 2003 to 2011
$16.7M
GENETIC REGULATION OF MUSCLE FIBER DIVERSITYR01GM061738 · NIGMS · UNIVERSITY OF NEW MEXICO · PI CRIPPS, RICHARD MATTHEW · 2001 to 2022
$6.4M
NCRR NIH HHS 1P20RR18754NCRR NIH HHS P20 RR018754NIGMS NIH HHS GM61738NIGMS NIH HHS R01 GM061738
6 · The paper itself

Abstract

The process of myogenesis requires the coordinated activation of many structural genes whose products are required for myofibril assembly, function, and regulation. Although numerous reports have documented the importance of the myogenic regulator myocyte enhancer factor 2 (MEF2) in muscle differentiation, the interaction of MEF2 with cofactors is critical to the realization of muscle fate. We identify here a genomic region required for full MEF2-mediated activation of actin gene expression in Drosophila, and we identify the zinc finger transcriptional regulator chorion factor 2 (CF2) as a factor functioning alongside MEF2 via this region. Furthermore, although both MEF2 and CF2 can individually activate actin gene expression, we demonstrate that these two factors collaborate in regulating the Actin57B target gene in vitro and in vivo. More globally, MEF2 and CF2 synergistically activate the enhancers of a number of muscle-specific genes, and loss of CF2 function in vivo results in reductions in the levels of several muscle structural gene transcripts. These findings validate a general importance of CF2 alongside MEF2 as a critical regulator of the myogenic program, identify a new regulator functioning with MEF2 to control cell fate, and provide insight into the network of regulatory events that shape the developing musculature.

Indexed as

Muscle DevelopmentAnimalsAnimals, Genetically Modifiedbeta-GalactosidaseBinding SitesCell Culture TechniquesCells, CulturedCulture Media, Serum-FreeDNA-Binding ProteinsDrosophilaDrosophila ProteinsEmbryo, NonmammalianGene Expression Regulation, DevelopmentalGenes, ReporterImmunohistochemistryIn Situ Hybridizationbeta-GalactosidaseCf2 protein, DrosophilaCulture Media, Serum-FreeDNA-Binding ProteinsDrosophila ProteinsMEF2 Transcription FactorsMyogenic Regulatory FactorsTranscription Factors

Identifiers

PMID18160709
PMCPMC2258795
OpenAlexW2109409960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.